325 related articles for article (PubMed ID: 5723803)
1. 28. Methadone maintenance and its implication for theories of narcotic addiction.
Dole VP; Nyswander ME
Res Publ Assoc Res Nerv Ment Dis; 1968; 46():359-66. PubMed ID: 5723803
[No Abstract] [Full Text] [Related]
2. XXVII. Opioid addiction problems in Canada.
Holmes SJ
Res Publ Assoc Res Nerv Ment Dis; 1968; 46():347-58. PubMed ID: 5723802
[No Abstract] [Full Text] [Related]
3. Pharmacological and societal factors in the management of drug dependence.
Jaffe J
Adv Biochem Psychopharmacol; 1973; 8(0):3-7. PubMed ID: 4800175
[No Abstract] [Full Text] [Related]
4. [Treatment of drug addicts with narcotic and non-narcotic drugs].
Koran LM
Bull Soc Sci Med Grand Duche Luxemb; 1972 Mar; 109(1):67-73. PubMed ID: 5056099
[No Abstract] [Full Text] [Related]
5. Addiction and the community. (Narcotic substitution therapy).
Taylor WJ; Chambers CD; Bowling CE
Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
[No Abstract] [Full Text] [Related]
6. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
Colker AC
Issue Brief Health Policy Track Serv; 2002 Dec; ():1-6. PubMed ID: 12875273
[No Abstract] [Full Text] [Related]
7. The use of drugs in the management of drug dependence.
Eddy NB
J Tenn Med Assoc; 1967 Mar; 60(3):269-73. PubMed ID: 6042204
[No Abstract] [Full Text] [Related]
8. Buprenorphine and naloxone interactions in methadone maintenance patients.
Mendelson J; Jones RT; Welm S; Brown J; Batki SL
Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for the opioid addict: agonists or antagonists?
Ketchum JS; Jarvik ME
Ration Drug Ther; 1979 Jan; 13(1):1-5. PubMed ID: 451229
[No Abstract] [Full Text] [Related]
10. The first methadone clinic in Beijing.
Humeniuk R; Ali R
Drug Alcohol Rev; 2005 May; 24(3):285-7. PubMed ID: 16096132
[No Abstract] [Full Text] [Related]
11. Multimodality treatment of narcotic addiction: an overview.
Woody GE; O'Brien CP; Greenstein R
NIDA Res Monogr; 1978; (19):226-40. PubMed ID: 106287
[TBL] [Abstract][Full Text] [Related]
12. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
Wikler A
Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072
[No Abstract] [Full Text] [Related]
13. [A clear look].
Vasseur V
Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B4. PubMed ID: 11104936
[No Abstract] [Full Text] [Related]
14. Treatment facilities for drug-dependent patients. Some impressions of treatment programmes in the United States and Canada.
Jensen GR
Med J Aust; 1973 Apr; 1(16):808-12. PubMed ID: 4707801
[No Abstract] [Full Text] [Related]
15. What's happening in hard-drug rehabilitation?
Walls RT; Gulkus SP
Rehabil Lit; 1973 Jan; 34(1):2-6. PubMed ID: 4683507
[No Abstract] [Full Text] [Related]
16. Pharmacotherapy of addictions.
Kreek MJ; LaForge KS; Butelman E
Nat Rev Drug Discov; 2002 Sep; 1(9):710-26. PubMed ID: 12209151
[TBL] [Abstract][Full Text] [Related]
17. Cyclazocine and methadone in narcotic addiction.
Freedman AM; Fink M; Sharoff R; Zaks A
JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
[No Abstract] [Full Text] [Related]
18. Insufficient information in drug-related hospital morbidity study.
Newman RG
Arch Gen Psychiatry; 2009 Mar; 66(3):331; author reply 331-2. PubMed ID: 19255384
[No Abstract] [Full Text] [Related]
19. Can psychotherapy rescue naltrexone treatment of opioid addiction?
Rounsaville BJ
NIDA Res Monogr; 1995; 150():37-52. PubMed ID: 8742771
[No Abstract] [Full Text] [Related]
20. [Methadone treatment. Psychological observations on a therapy of resignation].
Schneider M
Munch Med Wochenschr; 1973 Jul; 115(27):1233-6. PubMed ID: 4740750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
